Home/ Supplements/ Nicotinamide Riboside/ Liposomal Nicotinamide Riboside+

Liposomal Nicotinamide Riboside+

product on market Capsule Codeage Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Nicotinamide riboside and pterostilbene are studied for their roles in supporting NAD+ levels and cellular energy metabolism, though human evidence remains limited. Betaine anhydrous serves as a methyl donor to support metabolic processes. Overall, these ingredients have a strong safety profile, but clinical evidence for their combined efficacy is currently sparse.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Liposomal Nicotinamide Riboside+
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 300.0mg (26 products) 7 studies (A:0, B:1)
Market median: 496.0mg (192 products) 20 studies — no high-quality reviews
Market median: 167.0mg (311 products) 183 studies (A:0, B:65)

Other Ingredients

Methylcellulose Sunflower Oil
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Adults take 1 capsule daily, or as recommended by your healthcare practitioner, with 8 ounces of water or your favorite beverage. May be taken with or without food.

Warnings & Precautions

Caution: Do not exceed recommended dose. Discontinue use two weeks prior to surgery.

Pregnant or nursing mothers, children under 18 and individuals with a known medical condition should consult a physician before using this or any dietary supplement.

Pregnant or nursing mothers, children under 18 and individuals with a known medical condition should consult a physician before using this or any dietary supplement.

Please use caution if you have allergies or sensitivities to any of the listed ingredients.

Do not use if product has been opened or tampered with in any way.

Keep out of reach of children and pets.

Formulation Notes

Nicotinamide Riboside Betaine Anhydrous Trans-Pterostilbene Essential Phospholipids

Vegan

Non-GMO Soy-free Dairy-free Gluten-free

cGMP Certified Manufacturing

External Bioavailable

NR - TMG - Pterostilbene phospholipid complex

Additional Information

2-month supply

Please recycle bottle & cap Please take off the label Questions? codeage.com Scan for info

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU8 50049 60921 0
DSLD Entry Date2025-08-22
Product TypeOther Combinations
FormCapsule
BrandCodeage
DSLD ID333430
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
49
Avg Quality
8
Rct
1
Systematic Review
1
Clinical Trial
B Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
Rct Nature communications 2018 PubMed DOI
C The effects of NAD+ precursor (nicotinic acid and nicotinamide) supplementation on weight loss and related hormones: a systematic review and meta-regression analysis of randomized controlled trials
Systematic Review Frontiers in nutrition 2023 PubMed DOI
C Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial.
Rct Nature aging PubMed DOI
C Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
Rct Scientific reports 2019 PubMed DOI
C Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
Rct Cell reports 2019 PubMed DOI
C Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
Rct Aging cell 2023 PubMed DOI
C Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI
Rct BMC nephrology 2020 PubMed DOI
C Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19
Clinical Trial ClinicalTrials.gov 2021
C A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals.
Rct JCI insight PubMed DOI
C Nicotinamide Riboside Supplementation Benefits in Patients With Werner Syndrome: A Double-Blind Randomized Crossover Placebo-Controlled Trial.
Rct Aging cell PubMed DOI
View all evidence for Nicotinamide Riboside →
Compare

Similar Products

View all Nicotinamide Riboside products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.